Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD
The characteristics in AERD are severe adult-onset asthma, eosinophilic rhinosinusitis with nasal polyposis, and CysLT overproduction. The cause of AERD have remained unclear, however the decrease in the production of PGE2 caused by the reduction in COX-2 activity is considered to main pathological...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Allergology International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893019300589 |
id |
doaj-0aa72bacd3d24e7cb7ee2c164540077e |
---|---|
record_format |
Article |
spelling |
doaj-0aa72bacd3d24e7cb7ee2c164540077e2020-11-25T00:25:24ZengElsevierAllergology International1323-89302019-07-01683289295Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERDMasami Taniguchi0Chihiro Mitsui1Hiroaki Hayashi2Emiko Ono3Keiichi Kajiwara4Haruhisa Mita5Kentaro Watai6Yosuke Kamide7Yuma Fukutomi8Kiyoshi Sekiya9Noritaka Higashi10Corresponding author. National Hospital Organization Sagamihara National Hospital, Clinical Research Center, Sakuradai 18-1, Minami-ku, Sagamihara, Kanagawa 252-0392, Japan.; National Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanNational Hospital Organization Sagamihara National Hospital, Clinical Research Center, Kanagawa, JapanThe characteristics in AERD are severe adult-onset asthma, eosinophilic rhinosinusitis with nasal polyposis, and CysLT overproduction. The cause of AERD have remained unclear, however the decrease in the production of PGE2 caused by the reduction in COX-2 activity is considered to main pathological mechanism of AERD. The mast cell activation and the interaction between platelets and granulocytes are lead to the CysLT overproduction and severe eosinophilic inflammation. The ongoing activation of mast cells is important key pathogenesis in not only stable AERD but exacerbated AERD by aspirin and NSAIDs. In recent years, type 2 inflammation caused by ILC2 activation in patients with AERD have been attracting attention. Omalizumab is effective option for AERD via suppression of mast cell activation and CysLT overproduction. Dupilumab improves sinus symptoms especially in patients with AERD. In near future, anti-platelet drug, CRTH2 antagonist, and anti-TSLP antibody may be useful candidates of therapeutic options in patients with AERD. Keywords: AERD, Eosinophilic sinusitis, Leukotriene, Omalizumab, Severe asthmahttp://www.sciencedirect.com/science/article/pii/S1323893019300589 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Masami Taniguchi Chihiro Mitsui Hiroaki Hayashi Emiko Ono Keiichi Kajiwara Haruhisa Mita Kentaro Watai Yosuke Kamide Yuma Fukutomi Kiyoshi Sekiya Noritaka Higashi |
spellingShingle |
Masami Taniguchi Chihiro Mitsui Hiroaki Hayashi Emiko Ono Keiichi Kajiwara Haruhisa Mita Kentaro Watai Yosuke Kamide Yuma Fukutomi Kiyoshi Sekiya Noritaka Higashi Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD Allergology International |
author_facet |
Masami Taniguchi Chihiro Mitsui Hiroaki Hayashi Emiko Ono Keiichi Kajiwara Haruhisa Mita Kentaro Watai Yosuke Kamide Yuma Fukutomi Kiyoshi Sekiya Noritaka Higashi |
author_sort |
Masami Taniguchi |
title |
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD |
title_short |
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD |
title_full |
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD |
title_fullStr |
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD |
title_full_unstemmed |
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD |
title_sort |
aspirin-exacerbated respiratory disease (aerd): current understanding of aerd |
publisher |
Elsevier |
series |
Allergology International |
issn |
1323-8930 |
publishDate |
2019-07-01 |
description |
The characteristics in AERD are severe adult-onset asthma, eosinophilic rhinosinusitis with nasal polyposis, and CysLT overproduction. The cause of AERD have remained unclear, however the decrease in the production of PGE2 caused by the reduction in COX-2 activity is considered to main pathological mechanism of AERD. The mast cell activation and the interaction between platelets and granulocytes are lead to the CysLT overproduction and severe eosinophilic inflammation. The ongoing activation of mast cells is important key pathogenesis in not only stable AERD but exacerbated AERD by aspirin and NSAIDs. In recent years, type 2 inflammation caused by ILC2 activation in patients with AERD have been attracting attention. Omalizumab is effective option for AERD via suppression of mast cell activation and CysLT overproduction. Dupilumab improves sinus symptoms especially in patients with AERD. In near future, anti-platelet drug, CRTH2 antagonist, and anti-TSLP antibody may be useful candidates of therapeutic options in patients with AERD. Keywords: AERD, Eosinophilic sinusitis, Leukotriene, Omalizumab, Severe asthma |
url |
http://www.sciencedirect.com/science/article/pii/S1323893019300589 |
work_keys_str_mv |
AT masamitaniguchi aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT chihiromitsui aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT hiroakihayashi aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT emikoono aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT keiichikajiwara aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT haruhisamita aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT kentarowatai aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT yosukekamide aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT yumafukutomi aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT kiyoshisekiya aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd AT noritakahigashi aspirinexacerbatedrespiratorydiseaseaerdcurrentunderstandingofaerd |
_version_ |
1725349242101301248 |